Ahmadi et al. also evaluated 100 diffuse astrocytomas and found the lack of association between IDH1 mutation and clinical outcome in terms of OS, PFS and time to malignant progression [29]. This evidence concerns the gene IDH1 and diffuse astrocytoma.